| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 27, 2026 | ±3.6% | -1.6% | over-priced |
| February 25, 2026 | ±4.5% | +1.9% | over-priced |
| September 9, 2025 | ±2.8% | -0.8% | over-priced |
| May 28, 2025 | ±2.3% | -9.6% | under-priced |
| February 26, 2025 | ±4.4% | +2.7% | over-priced |
| August 23, 2024 | ±3.2% | -1.6% | over-priced |
| May 24, 2024 | ±2.5% | +0.2% | over-priced |
| February 23, 2024 | ±5.1% | -0.9% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $0.09 | $2.3B | $17M |
| Q1 FY2026 | $0.34 | $2.4B | $65M |
| Q4 FY2025 | $2.45 | $2.3B | $448M |
| Q3 FY2025 | $1.50 | $1.7B | $242M |
Synopsys Inc (SNPS) reports in 96 days, with the next report estimated for September 17, 2026. Across the last 8 reports, options priced an average ±3.5% earnings move while the stock actually moved 2.4% on average — the market has systematically over-priced SNPS's earnings risk. Fundamentals into the print: EPS down 95.9% year-over-year, revenue up 41.9%. QuantLogix's live 5-factor engine currently reads SNPS as a buy at 51/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →